Article
Nitric oxide synthase 2 (NOS2) promoter polymorphisms in colorectal cancer.
Cancer letters - 8 Jul 2005
Fransén Karin, Elander Nils, Söderkvist Peter
Abstract excerpt
Previously, increased expression of nitric oxide synthase 2 (NOS2) in colorectal cancer (CRC) has been identified. The NOS2 gene is transcriptionally regulated, which suggests that polymorphisms in the NOS2 promoter may have a role for CRC development and progression. The genotyping was performed with PCR/RFLP, single strand conformation analysis or MegaBACE genotyping of normal blood DNA from CRC patients and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
